FindTrial
Sign In

A study on the characteristics of a subtype of Breast cancer in a tertiary care hospital.

Clinical and radiological profile of triple negative breast cancer at a tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048834
Enrollment
90
Registered
2023-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Kasturba Medical College, Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All triple negative breast cancer patients above the age of 18

Exclusion criteria

Exclusion criteria: Patients with incomplete information regarding ER, PR, HER2/neu status.

Design outcomes

Primary

MeasureTime frame
Incidence of Triple negative breast cancer at our hospital. Pathological complete response in patients of Triple negative breast cancer. Surgical outcome in Triple negative breast cancer patients who underwent Neoadjuvant chemotherapy/radiation.Timepoint: 7 days post surgery—

Secondary

MeasureTime frame
Role of Neutrophil:Lymphocyte ratio in predicting Pathological complete response in Triple negative breast cancer.Timepoint: At admission and 7 days post surgery—

Countries

India

Contacts

Public ContactDr Vijayendra Kedage

Kasturba Medical College, Manipal

kallyarajgopalshenoy@gmail.com9845243460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026